BLFSBIOLIFE SOLUTIONS INC

Nasdaq biolifesolutions.com


$ 20.70 $ 1.16 (5.94 %)    

Monday, 13-May-2024 15:59:56 EDT
QQQ $ 442.96 $ 0.90 (0.2 %)
DIA $ 394.52 $ -0.66 (-0.17 %)
SPY $ 520.61 $ -0.23 (-0.04 %)
TLT $ 90.36 $ 0.25 (0.28 %)
GLD $ 216.28 $ -2.43 (-1.11 %)
$ 19.54
$ 20.97
$ 0.00 x 0
$ 0.00 x 0
$ 20.43 - $ 21.30
$ 8.92 - $ 24.50
1,692,948
na
887.75M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-29-2020 03-31-2020 10-Q
18 05-15-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-09-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-15-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-11-2018 03-31-2018 10-Q
26 03-09-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 03-15-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 03-12-2015 01-31-2015 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 benchmark-upgrades-biolife-solns-to-buy-announces-25-price-target

Benchmark analyst Robert Wasserman upgrades BioLife Solns (NASDAQ:BLFS) from Hold to Buy and announces $25 price target.

 biolife-solutions-reiterates-guidance

2024 Revenue GuidanceBioLife Solutions is affirming its 2024 revenue guidance of $95.5 million to $100.0 million. This is based...

 biolife-solns-q1-2024-gaap-eps-022-beats-028-estimate-sales-1620m-miss-2601m-estimate

BioLife Solns (NASDAQ:BLFS) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.28)...

 jefferies-initiates-coverage-on-biolife-solns-with-buy-rating-announces-price-target-of-22

Jefferies analyst Matthew Stanton initiates coverage on BioLife Solns (NASDAQ:BLFS) with a Buy rating and announces Price Ta...

 recap-biolife-solns-q4-earnings
Recap: BioLife Solns Q4 Earnings
02/29/2024 21:10:54

 biolife-solns-q4-2023-adj-eps-0210-beats-0340-estimate-sales-32732m-miss-33399m-estimate

BioLife Solns (NASDAQ:BLFS) reported quarterly losses of $(0.210) per share which beat the analyst consensus estimate of $(0.34...

 earnings-scheduled-for-february-29-2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on reve...

 earnings-scheduled-for-november-9-2023

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on re...

 over-1m-bet-on-carnival-check-out-these-3-stocks-insiders-are-buying

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

 top-5-health-care-stocks-that-could-blast-off-this-month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 stocks-that-hit-52-week-lows-on-friday

  During the Friday's sesion, 157 stocks hit new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION